Lister Ta
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
- Genetics 5
- Chronic Lymphocytic Leukemia Research 5
-
- Lymphoma Diagnosis and Treatment 5
- Co-authors
- BD Young (3 shared papers)Van de Ven Wj (1 shared paper)Pauline Parry (1 shared paper)Mark Bower (1 shared paper)J. Amess (1 shared paper)Gerald A. Evans (1 shared paper)D. Crowther (2 shared papers)R Powles (1 shared paper)
- Journals
- Blood (2 papers)PubMed (8 papers)UCL Discovery (University College London) (1 paper)
- Partner nations
- United KingdomUnited States
In The Last Decade
Lister Ta
11 papers receiving 324 citations
Peers
Comparison fields: 5 of 50
- Hematology 179
- Genetics 86
- Pathology and Forensic Medicine 56
- Oncology 75
- Public Health, Environmental and Occupational Health 69
Countries citing papers authored by Lister Ta
This map shows the geographic impact of Lister Ta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lister Ta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lister Ta more than expected).
Fields of papers citing papers by Lister Ta
This network shows the impact of papers produced by Lister Ta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lister Ta. The network helps show where Lister Ta may publish in the future.
Co-authors
The 22 scholars most cited alongside Lister Ta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A new member of the proprotein convertase gene family (LPC) is located at a chromosome translocation breakpoint in lymphomas. | 1996 | 88 |
| 2 | 1978 | 70 | |
| 3 | 1994 | 69 | |
| 4 | The treatment of acute myelogenous leukemia in adults. | 1972 | 52 |
| 5 | Staging for Hodgkin's disease. | 1990 | 16 |
| 6 | Posttreatment laparotomy as a guide to management in patients with Hodgkin's disease. | 1982 | 13 |
| 7 | Molecular cloning of a novel 11q23 breakpoint associated with non-Hodgkin's lymphoma. | 1994 | 12 |
| 8 | The use of high-dose cytosine arabinoside for non-Hodgkin's lymphoma. | 1985 | 11 |
| 9 | Limited activity of ICRF-159 in advanced acute leukemia. | 1979 | 9 |
| 10 | Conventional dose cytosine arabinoside in combination chemotherapy for acute myelogenous leukemia. | 1987 | 4 |
| 11 | VAPEC B: a weekly chemotherapy for high grade non-Hodgkin's lymphoma. Early results of a collaborative trial at two centres. | 1990 | 1 |
About Lister Ta
Lister Ta is a scholar working on Genetics, Pathology and Forensic Medicine, Hematology, Molecular Biology and Public Health, Environmental and Occupational Health, having authored 11 papers that have together received 345 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (5 papers), Acute Myeloid Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Multiple and Secondary Primary Cancers (2 papers), Glycosylation and Glycoproteins Research (1 paper), Ubiquitin and proteasome pathways (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Hematology (179 citations), Genetics (86 citations), Pathology and Forensic Medicine (56 citations), Oncology (75 citations) and Public Health, Environmental and Occupational Health (69 citations). Lister Ta has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include BD Young, Van de Ven Wj, Pauline Parry, Mark Bower, J. Amess, Gerald A. Evans, D. Crowther, R Powles, Susheela Dhut and Prentice Hg. Their work appears in journals such as Blood, PubMed and UCL Discovery (University College London).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.